A 34-year-old male recently began experiencing breast secretions while receiving Risperidone. The PMHNP understands that adding a 5HT2A antagonist action to D2 antagonism lessens the elevation of prolactin. Elevated prolactin is caused by what mechanism?

A. Serotonin B agonist: Activation of serotonin receptors influences mood and anxiety regulation but does not significantly impact prolactin secretion. Serotonergic effects are more commonly associated with appetite, mood, and sleep, not hormonal changes related to prolactin. B. D2 receptor blockade: Dopamine normally inhibits prolactin release from the anterior pituitary by binding to D2 receptors. When antipsychotics such as risperidone block these receptors, the inhibitory control of dopamine is lost, leading to increased prolactin secretion and symptoms such as galactorrhea and gynecomastia. C. Histamine 1 antagonism: Blocking histamine H1 receptors primarily causes sedation and weight gain due to effects on appetite and arousal pathways. It has little to no direct influence on prolactin secretion, making it an unlikely cause of the breast secretions seen here. D. Norepinephrine 1 antagonist: Alpha-1 adrenergic blockade leads to vasodilation and orthostatic hypotension. It does not alter dopaminergic control of prolactin release, so it is not associated with elevated prolactin levels in patients taking antipsychotic medications.